Search

Search Results

• INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

  Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley

  e2013023

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.023

  1907

  PDF: 685

  HTML: 669

  Table1: patient's characteristics: 138

  Table 2: profile of each patient: 163

• CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP

  Alessandro Laganà, Matteo Totaro, Maria Laura Bisegna, Loredana Elia, Stefania Intoppa, Marco Beldinanzi, Mabel Matarazzo, Mariangela di Trani, Alessandro Costa, Raffaele Maglione, Biancamaria Mandelli, Sabina Chiaretti, Maurizio Martelli, Maria Stefania De Propris

  e2024064

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.064

  1244

  PDF: 759

  Suppl. Files: 434

  Html: 98

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  1605

  PDF: 1602

  HTML: 751

• CD56⁺/CD38⁺ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia

  Alessandro Laganà, Matteo Breccia, Loredana Elia, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Sonia Buffolino, Attilio Di Lascio, Concetta Anna Germano, Stefania Intoppa, Maria Laura Milani, Maurizio Martelli, Massimo Breccia, Maria Stefania De Propris

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.049

  4

  PDF: 5

  Suppl. Files: 0

  HTML: 0

• Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma

  Muzaffer Keklik, Serdar Sivgin, Cigdem Pala, Celalettin Eroglu, Gulsah Akyol, Leylagul Kaynar, Mustafa Yavuz Koker, Demet Camlica, Ali Unal, Mustafa Cetin, Bulent Eser

  e2012063

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.063

  1354

  PDF: 705

  HTML: 4539

  Figure 1: Chest radiograph: 190

  Figure 2: Flow cytometer analysis of pleural fluid: 163

• “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

  Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

  e2016047

  2016-10-15

  https://doi.org/10.4084/mjhid.2016.047

  3958

  PDF: 1012

  HTML: 3556

  Untitled: 164

  Cneo. Fig.1: 99

  Untitled: 89

  Untitled: 112

  Untitled: 114

• PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

  Michele Bibas

  e2024007

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.007

  3428

  PDF: 2339

  HTML: 1411

• NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

  Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris

  e2024018

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.018

  890

  PDF: 1244

  Suppl. Files: 816

  HTML: 145

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2520

  PDF: 1569

  HTML: 2337

  Table1: 176

• PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

  Giuseppe G.M. Leone, Ugo Testa

  e2025080

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.080

  869

  PDF: 299

  Html: 68

• CYTOKINE RESPONSE ASSOCIATED WITH HEPATITIS C VIRUS CLEARANCE IN HIV COINFECTED PATIENTS INITIATING PEG INTERFERON-? BASED THERAPY.

  Truong Tam Nguyen, Reihani Niloofar, Pierre-Alain Rubbo, Kuster Nils, Karine Bollore, Jacques Ducos, Georges-Philippe Pageaux, Jacques Reynes, Philippe Van de Perre, Edouard Tuaillon

  e2016003

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.003

  3065

  PDF: 854

  HTML: 2033

  Untitled: 163

• CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES

  Ugo Testa, Prof. Patrizia Chiusolo, Dr. Elvira Pelosi, Dr. Germana Castelli, Giuseppe Leone

  e2024031

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.031

  2078

  PDF: 1929

  HTML: 143

• MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

  Francesca Fazio, Gianfranco Lapietra, Maria Zaira Limongi, Stefania Intoppa, Maria Laura Milani, Alfonso Piciocchi, Maurizio Martelli, Anna Guarini, Robin Foà, Maria Stefania De Propris, Maria Teresa Petrucci

  e2023047

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.047

  905

  PDF: 658

  HTML: 259

• PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

  Ugo Testa; Giuseppe G.M. Leone

  e2025005

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.005

  2372

  HTML: 252

  PDF: 823

• CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

  Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone

  e2013031

  2013-05-01

  https://doi.org/10.4084/mjhid.2013.031

  3042

  PDF: 858

  HTML: 1524

  Fig.1 CHL-R paper: 191

  Fig 2 CHL-R paper: 219

• SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE

  Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, Subhajit Brahma, Asish Rath, Sundar Shewale, Mayur Parihar, Manish Singh, Arun SR, Shekhar Krishnan, Arpita Bhattacharyya, Anirban Das, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Reena nair, Mammen Chandy, Neeraj Arora, Deepak Kumar Mishra

  e2019017

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.017

  3026

  PDF: 1572

  HTML: 416

• IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

  Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos

  e2012052

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.052

  2973

  PDF: 836

  HTML: 7150

  Kost Fig1: 164

  Kost Fig 2: 156

  Kost Fig3: 151

  Kost Fig 4: 169

  Kost Fig5: 166

  Kost fig 6: 151

• WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

  Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi

  e2018004

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.004

  7241

  PDF: 2372

  HTML: 1705

  Table 1.: 183

  Table 2.: 199

  Table 3.: 180

  Table 4.: 179

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1446

  PDF: 1262

  HTML: 105

• INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS)

  Alessandro Laganà, Raffaele Maglione, Alessandro Costa, Biancamaria Mandelli, Maria Laura Bisegna, Maria Laura Milani, Valeria Filipponi, Maria Grazia Nardacci, Tania Soriano, Eugenio Santacroce, Luigi Petrucci, Carla Giordano, Maurizio Martelli, Maria Stefania De Propris

  e2025.002

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.002

  2025

  PDF: 1392

  HTML: 316

  PDF: 992

• POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

  Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.028

  562

  PDF: 280

  Suppl. Files: 103

  HTML: 96

• Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

  Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

  e2025026

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.026

  1772

  PDF: 1529

  HTML: 115

• MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

  Maria Ilaria Del Principe

  e2016052

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.052

  4561

  PDF: 1282

  HTML: 1888

  Untitled: 165

  Untitled: 163

• ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

  Maria L. Delioukina, Stephen J. Forman

  e2010018

  2010-06-30

  https://doi.org/10.4084/mjhid.2010.018

  1190

  PDF: 766

  HTML: 526

• CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira

  e2016024

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.024

  4464

  PDF: 1295

  HTML: 4591

• ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica

  e2010026

  2010-08-31

  https://doi.org/10.4084/mjhid.2010.026

  1315

  PDF: 732

  HTML: 931

• SOLITARY PLASMACYTOMA

  Sara Grammatico, Emilia Scalzulli, Maria Teresa Petrucci

  e2017052

  2017-08-23

  https://doi.org/10.4084/mjhid.2017.052

  3751

  PDF: 2127

  HTML: 1199

  fIGURES 1,2: 191

• Psychiatric Symptoms after H1N1 Influenza Treated with Baloxavir Marboxil in Two Patients with Hematologic Malignancies

  Zhan Su, Xiaojia Bu, Yao Li

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.031

  455

  PDF: 280

  HTML: 59

• REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

  Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst

  e2021012

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.012

  1481

  PDF: 560

  HTML: 170

• CHRONIC LYMPHOCYTIC LEUKAEMIA: CENSUS OF PATIENTS TREATED IN ITALIAN HAEMATOLOGY UNITS

  Gianfranco Salvi

  e2015056

  2015-10-18

  https://doi.org/10.4084/mjhid.2015.056

  1405

  PDF: 943

  HTML: 1890

• Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

  Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez

  e2022013

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.013

  1043

  PDF: 511

  HTML: 207

• Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

  Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani

  e2025027

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.027

  1302

  PDF: 1166

  HTML: 248

• T-CELL RECEPTOR (TCR)-VΒ REPERTOIRE FLOW CYTOMETRY FOR T-CELL LYMPHOPROLIFERATIVE DISORDER: A RETROSPECTIVE ANALYSIS OF A SINGLE-CENTER REAL-LIFE LABORATORY EXPERIENCE

  Marco Antonacci, Jacopo Micozzi, Alessandro Costa, Alessandro Laganà, Maria Laura Milani, Stefania Intoppa, Vittorio Bellomarino, Maria Grazia Nardacci, Mario Biglietto, Stefano Imperatore, Maria Laura Bisegna, Maurizio Martelli, Irene Della Starza, Maria Stefania De Propris

  e2025016

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.016

  1250

  PDF: 844

  Suppl. Files: 610

  HTML: 130

• Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

  Edoardo Olivari

  e2025040

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.040

  953

  PDF: 727

  HTML: 141

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  3999

  PDF: 1534

  HTML: 840

• Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells

  Dina Sameh Soliman, Hesham Elsabah, Ibrahim Ganwo, Aliaa Amer, Ruba Y Taha, Lajos Szabados , Mouhammad Sharaf Eldean, Ahmad Al-Sabbagh, Feryal Ibrahim

  e2021043

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.043

  1440

  PDF: 353

  HTML: 183

• Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs

  Feiying Meng

  e2021041

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.041

  1072

  PDF: 459

  HTML: 212

• Fusion Gene Landscape in a Case of Acute Myelocytic Leukemia with Myelocyte Morphology

  Zhan Su, Yan Li, Haidong Zhu, Yaqi Wang, Meiying Yang

  e2025004

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.004

  1146

  PDF: 977

  HTML: 145

• Utility of flow cytometry ascitic fluid analysis for rapid diagnosis of B-cell peritoneal lymphomatosis

  Maria Laura Bisegna, Niccolò Noccioli, Irene Della Starza, Alice Di Rocco, Nadia Peragine, Maria Stefania De Propris

  e2022068

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.068

  694

  PDF: 445

  HTML: 275

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1297

  HTML: 368

  PDF: 793

• REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio

  e2012053

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.053

  2254

  PDF: 939

  HTML: 7606

  Untitled: 254

  Fig2: 163

  Fig3: 143

  Fig4: 162

• Isavuconazole successfully treated pulmonary mucormycosis in acute myeloid leukemia: A case report

  Hong Chen, Kun Chen, wenqiang kong

  e2025031

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.031

  782

  PDF: 682

  HTML: 65

• Peripheral T-Cell Lymphoma in mediastinum lymph nodes and lung associated to histoplasmosis in a patient with Chronic Lymphoid Leukemia/Small Lymphocytic Lymphoma

  Cristiano Claudino Oliveira

  e2017044

  2017-06-20

  https://doi.org/10.4084/mjhid.2017.044

  1126

  PDF: 777

  HTML: 969

  Untitled: 208

• LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

  kang sun

  e2024037

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.037

  2545

  PDF: 1047

  HTML: 99

• Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

  Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo

  e2019057

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.057

  1486

  PDF: 925

  HTML: 222

• CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

  Ugo Testa, Elvira Pelosi, Dr. Germana Castelli

  e2024077

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.077

  1648

  PDF: 796

  HTML: 137

• DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

  Sabina Chiaretti, Gina Zini, Renato Bassan

  e2014073

  2014-10-24

  https://doi.org/10.4084/mjhid.2014.073

  8871

  PDF: 5957

  HTML: 87459

  Fig.1b: 164

  Fig.1c: 165

  Fig.2a: 156

  Fig.2b: 161

  Fig.4: 169

  Fig.2c: 158

  Fig.3: 163

  Tab.1: 212

  Tab.2: 191

  Tab.3: 177

  Tab.4: 198

  Fig1a: 158

• The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

  Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso

  e2022041

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.041

  1165

  PDF: 732

  HTML: 296

• Pathologic splenic rupture in a patient with follicular lymphoma

  Aniruddha P Dayama, Rajan Kapoor, Jasmita Dass, Gurmeet Singh, Manoranjan Mahapatra, Haraprasad Pati

  e2011051

  2011-11-10

  https://doi.org/10.4084/mjhid.2011.051

  1381

  PDF: 522

  HTML: 1171

  rupture: 161

• DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.

  Matteo Della Porta, Cristina Picone

  e2017017

  2017-02-15

  https://doi.org/10.4084/mjhid.2017.017

  4662

  PDF: 1742

  HTML: 2100